Clinical Care Options Prostate Cancer This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

CHAARTED: QoL Analysis of Docetaxel + ADT in Metastatic Hormone-Sensitive Prostate Cancer
Slideset - Patient-reported outcomes from CHAARTED indicate that adding docetaxel to ADT increased physical symptoms during first 3 months of treatment but was associated with significantly improved QoL at 12 mos in patients with mHSPC. (Source: Clinical Care Options Prostate Cancer)
Source: Clinical Care Options Prostate Cancer - June 7, 2016 Category: Cancer & Oncology Source Type: research

Retreatment With Radium-223 Safe, Showing Activity in Patients With CRPC and Bone Metastases
Slideset - Results from this small exploratory study suggest that radium-223 retreatment is well tolerated and may help delay future bone events in patients with CRPC and bone metastases who experience radiographic or clinical progression following an initial course of radium-223. (Source: Clinical Care Options Prostate Cancer)
Source: Clinical Care Options Prostate Cancer - June 7, 2016 Category: Cancer & Oncology Source Type: research

FIRSTANA: Cabazitaxel Not Superior to Docetaxel in Chemotherapy-Naive mCRPC
Slideset - Cabazitaxel and docetaxel show similar clinical activity in mCRPC but with distinct safety profiles. (Source: Clinical Care Options Prostate Cancer)
Source: Clinical Care Options Prostate Cancer - June 7, 2016 Category: Cancer & Oncology Source Type: research

Sequencing Considerations After Progression Following Initial Therapy for mCRPC
Slideset - In this downloadable slideset, Tanya B. Dorff, MD, reviews current and emerging evidence for the management of patients with metastatic CRPC and progression on previous systemic therapy. (Source: Clinical Care Options Prostate Cancer)
Source: Clinical Care Options Prostate Cancer - June 7, 2016 Category: Cancer & Oncology Source Type: research

Newly Diagnosed Metastatic Castration Resistant Prostate Cancer
Slideset - In this downloadable slideset, Andrew J. Armstrong, MD, ScM, FACP, reviews current evidence and guidelines related to the management of patients with newly diagnosed metastatic CRPC. (Source: Clinical Care Options Prostate Cancer)
Source: Clinical Care Options Prostate Cancer - June 7, 2016 Category: Cancer & Oncology Source Type: research

Metastatic Prostate Cancer: Latest Developments Changing Care in the Clinic
Slideset - In this downloadable slideset, Celestia S. Higano, MD, FACP, provides an overview of current guidelines and expert recommendations for the management of patients with metastatic prostate cancer. (Source: Clinical Care Options Prostate Cancer)
Source: Clinical Care Options Prostate Cancer - June 7, 2016 Category: Cancer & Oncology Source Type: research

Approach to Metastatic Hormone-Sensitive Prostate Cancer
Slideset -Alan H. Bryce, MD Current evidence and guidelines related to the management of patients with metastatic hormone sensitive prostate cancer (Source: Clinical Care Options Prostate Cancer)
Source: Clinical Care Options Prostate Cancer - June 6, 2016 Category: Cancer & Oncology Source Type: research

Approach to Metastatic Hormone-Sensitive Prostate Cancer
Slideset - In this downloadable slideset, Alan H. Bryce, MD, reviews current evidence and guidelines related to the management of patients with metastatic hormone sensitive prostate cancer. (Source: Clinical Care Options Prostate Cancer)
Source: Clinical Care Options Prostate Cancer - June 6, 2016 Category: Cancer & Oncology Source Type: research

GU Malignancies at the 2016 Clinical Oncology Meeting: In Anticipation of Practice-Changing Data
Discussion - Here are my thoughts on the abstracts from ASCO 2016 that have the most potential to change clinical practice. (Source: Clinical Care Options Prostate Cancer)
Source: Clinical Care Options Prostate Cancer - May 31, 2016 Category: Cancer & Oncology Source Type: research

Genitourinary Cancers
Slideset - In this downloadable slideset, David F. McDermott, MD, and Daniel P. Petrylak, MD, review key studies presented at the 2015 American Society of Clinical Oncology Annual Meeting relevant to the management of patients with prostate, kidney, or bladder cancers. (Source: Clinical Care Options Prostate Cancer)
Source: Clinical Care Options Prostate Cancer - August 20, 2015 Category: Cancer & Oncology Source Type: research

Genitourinary Cancer
Learning Module - David F. McDermott, MD, and Daniel P. Petrylak, MD, provide their analysis of key genitourinary cancer presentations from the 2015 clinical oncology meeting in Chicago. (Source: Clinical Care Options Prostate Cancer)
Source: Clinical Care Options Prostate Cancer - August 13, 2015 Category: Cancer & Oncology Source Type: research

SYNERGY: Custirsen in Poor-Prognosis mCRPC
Slideset - A retrospective exploratory analysis of the phase III SYNERGY trial shows that adding custirsen to docetaxel/prednisone selectively improves survival in treatment-naive patients with mCRPC and a poor prognosis. (Source: Clinical Care Options Prostate Cancer)
Source: Clinical Care Options Prostate Cancer - June 5, 2015 Category: Cancer & Oncology Source Type: research